-
Cardio Diagnostics (CDIO) Regains Nasdaq Compliance
-
Cardio Diagnostics (CDIO) Announces 1:30 Reverse Share Split
-
Cardio Diagnostics (CDIO) Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services for AI-Powered Cardiovascular Tests
-
Cardio Diagnostics (CDIO) Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

